UC Davis MIND Institute researchers to establish new tests to evaluate cognitive growth in people with intellectual disability
October 30, 2014
Researchers with the UC Davis MIND Institute will develop and evaluate tests designed to measure and track changes in the cognitive functioning of people who typically are difficult to assess accurately: those with an intellectual disability, formerly termed mental retardation. The research will be funded through a new, five-year, $3.2 million grant from the National Institutes of Health (NIH).
October 28, 2014
The National Cancer Institute (NCI) has awarded a $2.7 million grant to UC Davis researchers to investigate how the so-called Western diet, which is high in fat and sugar, increases the risk of developing liver and gastrointestinal (GI) cancers. In addition, the researchers will study whether bifidobacteria, a common family of bacteria in the human gut, can be enriched to prevent cancer.
October 27, 2014
A team of UC Davis scientists has found that administering a small molecule – purmorphamine – in animal models after a stroke results in multiple protective effects, including reducing the size of the stroke, decreasing inflammation and increasing markers for nerve regeneration.
October 24, 2014
Researchers at UC Davis have found that the drug bortezomib effectively treats chronic graft-versus-host disease (GVHD), a common and debilitating side effect from allogeneic hematopoietic stem cell transplants.
October 24, 2014
The American Academy on Communication in Healthcare (AACH) has recognized Richard Kravitz, professor of internal medicine, with its George Engel Award. The award is presented annually for outstanding research contributing to the theory, practice and teaching of effective health-care communication and related skills.
October 20, 2014
Researchers at the University of California, Davis, Lawrence Berkeley National Laboratory and Marine Biological Laboratory in Woods Hole, Massachusetts, have created a cellular probe that combines a tarantula toxin with a fluorescent compound to help scientists observe electrical activity in neurons and other cells. The probe binds to a voltage-activated potassium ion channel subtype, lighting up when the channel is turned off and dimming when it is activated.
October 10, 2014
A multidisciplinary team at UC Davis will embark on research to determine whether combining a novel type of immunotherapy with radiation and chemotherapy can make treatment for sarcoma, breast and pancreatic cancers more effective.
October 10, 2014
A team of UC Davis and University of Arizona researchers discovered that adding the bacteria Bifidobacterium longum subsp. infantis (B. infantis) to formula fed to newborn rats reduced the incidence of necrotizing enterocolitis, an often deadly intestinal infection.
MIND Institute receives $900,000 grant to study use of sertraline in young children with autism spectrum disorder
October 8, 2014
Focusing on treatments to ameliorate autism symptoms, researchers with the UC Davis MIND Institute will launch the first study to examine the effectiveness of the use of sertraline, commonly known as Zoloft®™, in children as young as 2 to 6 years, through a three-year, $900,000 grant from the U.S. Health Resources and Services Administration (HRSA).
October 6, 2014
How alterations in a single gene on the X chromosome affects neurological and psychological functioning in men as they age is the subject of a new study by UC Davis MIND Institute researchers.
September 30, 2014
Two UC Davis research teams developing transformational technologies to understand the dynamics of the neural circuitry underlying behavior and cognition have received awards from the federal Brain Research through Advancing Innovative Technologies (BRAIN) Initiative, a presidential grand Challenge enterprise.
September 24, 2014
The UC Davis Comprehensive Cancer Center’s Brain Innovation Group has received a grant from the National Cancer Institute (NCI) to improve brain cancer surgery and treatment using UC Davis-developed biophotonic technology.
September 23, 2014
A 2004 California law mandating specific nurse-to-patient staffing standards in acute care hospitals significantly lowered job-related injuries and illnesses for both registered nurses and licensed practical nurses, according to a UC Davis study published online in the International Archives of Occupational and Environmental Health.
September 21, 2014
Mothers of children with autism are significantly less likely to report taking iron supplements before and during their pregnancies than the mothers of children who are developing normally, a study by researchers with the UC Davis MIND Institute has found.
September 12, 2014
In what may be the largest study of sleep problems among individuals with multiple sclerosis (MS), researchers at UC Davis have found that widely undiagnosed sleep disorders may be at the root of the most common and disabling symptom of the disease: fatigue.
September 11, 2014
Noriko Satake, UC Davis pediatric oncologist and researcher, has demonstrated in laboratory studies that a new, targeted treatment for leukemia is effective.
September 8, 2014
Treatment at the earliest age when signs of autism spectrum disorder (ASD) appear – sometimes in infants as young as 6 months old – significantly reduces symptoms so that, by age 3, most who received the therapy had neither ASD nor developmental delay, a UC Davis MIND Institute research study has found. [español]
September 3, 2014
Infant rhesus monkeys receiving different diets early in life develop distinct immune systems that persist months after weaning, a study by researchers from UC Davis, the California National Primate Research Center (CNPRC) at UC Davis and UC San Francisco has shown. The study, which compares breast- and bottle-fed infants, appears online September 3 in Science Translational Medicine. [en español]
September 2, 2014
Short questionnaires used to identify patients at risk for depression are linked with antidepressant medications being prescribed when they may not be needed, according to new research from UC Davis Health System published in the September-October issue of the Journal of the American Board of Family Medicine.
August 29, 2014
Researchers at UC Davis have made some surprising discoveries about the body’s initial responses to HIV infection. Studying simian immunodeficiency virus (SIV), the team found that specialized cells in the intestine called Paneth cells are early responders to viral invasion and are the source of gut inflammation by producing a cytokine called interleukin-1 beta (IL-1β).
August 28, 2014
Autism is far more common in boys than girls - affecting 1 in 54 boys and 1 in 252 girls — but little is known about biological differences between boys and girls with autism. A new study, called the ‘Girls with Autism — Imaging of Neurodevelopment’ or GAIN Study, led by researchers at the UC Davis MIND Institute will explore those differences in very young girls with autism.
August 26, 2014
mKit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles can be used as contrast agents to light up tumors for MRI and PET scans or deliver chemo and other therapies to destroy tumors. In addition, the particles are biocompatible and have shown no toxicity. The study was published online today in Nature Communications.
August 13, 2014
Bringing together the research prowess of the University of California to address the increase in autism incidence, its public health impacts, and the need to speed the development of treatments for affected individuals and their families, internationally respected scientists from UC campuses at Irvine, Los Angeles, San Diego, San Francisco and Davis will converge at the UC Davis MIND Institute for a daylong summit on innovative translational neurodevelopmental research.
August 11, 2014
Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells.
August 7, 2014
UC Davis Comprehensive Cancer Center oncologist Chong-Xian Pan has received a $650,000 grant from the VA Northern California Health Care System to conduct the first clinical trial of a novel chemotherapy-delivery drug he developed for bladder cancer patients.
August 6, 2014
Lin Tian’s fascination with neuroscience stems from a deep curiosity about the complexity and elegance of the human brain. As one of only five scientists in the U.S. and Canada — and the first at UC Davis —to be named a 2014 Rita Allen Foundation Scholar, Tian will be developing optical sensors and applications to acquire fundamental insights about how the nervous system functions in health and disease.
August 5, 2014
Founding Dean for the Betty Irene Moore School of Nursing at UC Davis, Heather M. Young, was recently named the 2014 recipient of the Doris Schwartz Gerontological Nursing Research Award by the nation’s largest interdisciplinary organization devoted to the field of aging — the Gerontological Society of America (GSA).
UC Davis nursing school approved for $2.1 million award by the Patient-Centered Outcomes Research Institute
July 31, 2014
A research project led by the Betty Irene Moore School of Nursing at UC Davis was approved for a $2.1 million award by the Patient-Centered Outcomes Research Institute (PCORI) to study improving health for individuals with diabetes.
July 24, 2014
Early life experiences, such as childhood socioeconomic status and literacy, may have greater influence on the risk of cognitive impairment late in life than such demographic characteristics as race and ethnicity, a large study by researchers with the UC Davis Alzheimer’s Disease Center and the University of Victoria, Canada, has found.
July 24, 2014
While having children or being female is often thought to be linked with the decision to leave a general surgery residency, this is not true, according to a 10-year evaluation of UC Davis residents.
UC Davis study researches potential link to care for mothers battling depression: their child's pediatrician
July 21, 2014
Pediatricians will screen mothers for depression in a new research study conducted at UC Davis Children's Hospital. The grant is funded by the National Institute of Mental Health.
July 18, 2014
UC Davis MIND Institute researchers are seeking participants for a new study that will examine the early development of infants who have an older sibling with autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), or who are developing typically. In an effort to detect the earliest signs of developmental problems, the researchers will test a new online screening measure that uses videos to help parents track their infants’ development.
July 18, 2014
No Stomach for Cancer Foundation (NSFC) has awarded cancer geneticist Luis Carvajal-Carmona a $50,000 grant to study the genetic characteristics of gastric cancer.
July 18, 2014
Researchers from UC Davis School of Medicine and Shriners Hospitals for Children – Northern California have identified a group of cells in the brain that they say plays an important role in the abnormal neuron development in Down syndrome.
July 17, 2014
The current system used to determine Medicare payments for surgeries — called relative value units, or RVUs — poorly correlates with the actual work involved in procedures, new research from UC Davis has found. The authors of the study, which will be published in the August issue of the Journal of Surgical Research, call for a more objective system for determining the value of work done by surgeons.
July 15, 2014
Researchers at UC Davis School of Medicine have for the first time shown that a polysialylated glycoprotein that regulates neurodevelopment exists on the surface of cells in the adult inner ear.
July 14, 2014
The Hartwell Foundation has presented an Individual Biomedical Research Award to Professor Judy A. Van de Water of the University of California, Davis, recognizing research that could affect nearly one in every four cases of autism among children in the U.S.
July 14, 2014
Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor’s ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences.
July 10, 2014
When it comes to a specific type of pancreatic surgery, post-operative complications have a far greater impact on total cost than does how long the patient stays in the hospital, according to a published paper by UC Davis researchers.
July 7, 2014
A nationwide study of more than 40,000 children evaluated in hospital emergency departments for head trauma found that if children had only loss of consciousness, and no other signs or symptoms related to the head trauma, they are very unlikely to have sustained serious brain injuries. Children who have only isolated loss of consciousness after head trauma do not routinely require computed tomography (CT) scans of the head, reported researchers from UC Davis Health System and Boston Children’s Hospital.
July 2, 2014
A potentially groundbreaking investigational drug designed to treat the painful vaso-occlusive crises that are the hallmark of sickle cell disease has been found to be safe following a clinical trial at UC Davis.
June 26, 2014
Researchers at UC Davis have determined that surgical biopsies can be safely performed on select patients with late-stage non-small cell lung cancer, which should enhance their access to drugs that target specific genetic mutations such as epidermal growth factor receptor (EGFR).
June 24, 2014
A UC Davis program designed to better manage cancer patients taking oral chemotherapy drugs has demonstrated that one-on-one counseling, education and monitoring can improve adherence to potentially life-saving cancer treatments.
UC Davis MIND Institute study finds association between maternal exposure to agricultural pesticides, autism in offspring
June 22, 2014
Pregnant women who lived in close proximity to fields and farms where chemical pesticides were applied experienced a two-thirds increased risk of having a child with autism spectrum disorder or other developmental delay, a study by researchers with the UC Davis MIND Institute has found. The associations were stronger when the exposures occurred during the second and third trimesters of the women’s pregnancies. [en español]
June 16, 2014
UC Davis Comprehensive Cancer Center patients will soon be part of an unprecedented clinical trial designed to improve access to promising therapies and speed development of effective treatments for an advanced form of lung cancer, the leading cancer killer of both men and women.
June 11, 2014
In a remarkable series of experiments on a fungus that causes cryptococcal meningitis, a deadly infection of the membranes that cover the spinal cord and brain, investigators at UC Davis have isolated a protein that appears to be responsible for the fungus’ ability to cross from the bloodstream into the brain.
June 10, 2014
A UC Davis study comparing violent misdemeanor convictions with their original criminal charges has found that subsequent violent crimes could be prevented if criminal charges were reduced less often during plea bargaining.
May 30, 2014
Devices made of metal plates and screws that can precisely align and stabilize fractured bones as they heal can safely and effectively repair the sternum, according to a review of UC Davis surgeries published in the May issue of the Annals of Plastic Surgery.
May 29, 2014
Paramita Ghosh, a UC Davis associate professor and expert in signal transduction pathways in prostate cancer, has been selected as one of 350 scientists to work on a project that aims to reduce public exposure to environmental agents that can lead to cancer and that hopes to inspire research into multi-faceted approaches to cancer prevention, treatment and prolonged survival.
May 14, 2014
Even if treated, hypertension and high cholesterol are common for people with human immunodeficiency virus (HIV), according to a new study from researchers at Mount Sinai St. Luke’s and Mount Sinai Roosevelt hospitals in New York and the University of California, Davis.
May 12, 2014
Colorectal cancer screening saves lives, but too few people get tested. In an effort to increase these numbers,researchers from UC Davis and elsewhere investigated whether an individualized interactive multimedia computer program (IMCP) would spur patients to get screened.
May 8, 2014
Children with autism experience deficits in a type of immune cell that protects the body from infection. Called granulocytes, the cells exhibit one-third the capacity to fight infection and protect the body from invasion compared to the same cells in children who are developing normally.
April 30, 2014
The five University of California medical centers and their affiliates participating in the Athena Breast Health Network are using a new guide for sharing electronic data for breast cancer treatment. Developed by the American Society of Clinical Oncology (ASCO) and approved through ASCO's Health Level Seven International committee (HL7), the guide will become a national data exchange standard. With the guide, Athena can utilize structured data capture tools for coordination of care, registry submission and research.
April 28, 2014
The stress hormone epinephrine – the source of the “fight-or-flight” response – also heightens stresses at the cellular level, inhibiting wound healing and promoting a state of chronic inflammation that prohibits the body’s stem cells from migrating to a wound to encourage skin regeneration, UC Davis researchers have found.
April 22, 2014
Researchers at UC Davis Children’s Hospital have shown that children with Down syndrome have significantly better in-hospital survival rates after surgeries for congenital heart disease (CHD) than their genetically typical peers.
April 22, 2014
The risk of pregnancy among women using a newer method of planned sterilization called hysteroscopic sterilization is more than 10 times greater over a10-year period than using more commonly performed laparoscopic sterilization, a study by researchers with Yale University and UC Davis has found.
April 17, 2014
Researchers at UC Davis have identified a new feature of the genetic mutation responsible for the progressive neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS) — the formation of “R-loops,” which they believe may be associated with the disorder’s neurological symptoms, such as tremors, lack of balance, features of parkinsonism, and cognitive decline.
April 17, 2014
An international team led by researchers at UC Davis has shown that the cyclin B1/Cdk1 protein complex, which plays a key role in cell division, also boosts the mitochondrial activity to power that process. This is the first time the complex has been shown to perform both jobs. This newfound ability could make cyclin B1/Cdk1 an excellent target to control cellular energy production, potentially advancing cancer care and regenerative medicine. The research was published online today in the journal Developmental Cell.
April 14, 2014
Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs), medications frequently prescribed to treat depression, anxiety and other mental-health disorders, is associated with a higher incidence of autism spectrum disorder (ASD) and developmental delays (DD) in male children, a study of nearly 1,000 mother-child pairs has found.
April 8, 2014
Federal agencies responsible for tracking workplace hazards fail to report 77 percent of the injuries and illnesses of U.S. agricultural workers and farmers, new research from UC Davis has found. [en español]
April 7, 2014
A multidisciplinary research team at UC Davis has found a key biological trigger — a protein known as nitric oxide synthase, or NOS — that makes the heart beat stronger in response to higher blood pressure, along with a way to turn that trigger off when it becomes overactive.
April 3, 2014
Jesse De La Cruz didn’t have any hepatitis C symptoms for nearly 15 years. Physicians say that’s fairly typical of an illness also known as “the silent killer.”
April 2, 2014
The very earliest signs of a debilitating neurodegenerative disorder, in which physical symptoms are not apparent until the fifth decade of life, are detectable in individuals as young as 30 years old using a new, sophisticated type of neuroimaging, researchers at UC Davis, the University of Illinois and UCLA have found.
April 1, 2014
A new technology can simultaneously detect as many as 100 clinically important protein molecules in breast tumor cells – a quantum advance over conventional methods that can pinpoint only two to four at the same time. The advantages of the new methodology, called multiplexed ion beam imaging (MIBI), is described by a team of scientists at UC Davis and San Francisco and at Stanford, Genentec in the March 23 advance online publication of the journal Nature Medicine.
March 26, 2014
Blood and tumor specimen collection from cancer patients is critical to research into new, more personally targeted therapies. But biospecimen collection among diverse populations lags far behind that of whites. [Chinese, Vietnamese and Spanish]
March 24, 2014
UC Davis professor Christopher Bowlus of the Division of Gastroenterology and Hepatology, and his liver cancer disparity research, are featured on the Health Equity Research Snapshot of the Association of American Medical Colleges (AAMC).
March 21, 2014
After nine years and countless fund-raising events, the Placer Breast Cancer Endowment on Thursday reached its goal of $1.5 million for breast cancer research at UC Davis Comprehensive Cancer Center.
March 21, 2014
For the first time, scientists have succeeded in coaxing laboratory cultures of human stem cells to develop into the specialized, unique cells needed to repair a patient’s defective or diseased bladder.
March 20, 2014
Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The study also found that radiation treatments did not significantly impair the immune response. The paper was published on March 10 in the journal Cancer Immunology Research, an American Association for Cancer Research (AACR) publication.
March 19, 2014
UC Davis clinicians and physicists have recommended new strategies to make computed tomography (CT) safer, including adoption of a new metric for dose measurement, ways to manage exposure protocols that differ by CT brand and specific approaches to reduce exposure during needle biopsies. The recommendations are detailed in papers published in the March issue of the Journal of the American College of Radiology (JACR).
March 18, 2014
Twenty years after Congress mandated that research funded by the National Institutes of Health include minorities, less than 5 percent of trials participants are non-white, and less than 2 percent of clinical cancer research studies focus on non-white ethnic or racial groups, UC Davis researchers have found. [Chinese, Spanish, Korean, Vietnamese]
March 18, 2014
A new study involving researchers from UC Davis and four other National Cancer Institute-designated cancer centers reveals important barriers that limit minority group participation in cancer clinical trials, findings that will be used to refine and launch more effective strategies to assure that more minorities benefit from clinical trials.
March 17, 2014
Mothers of newborns can now donate their babies’ umbilical cord blood at UC Davis Medical Center and other hospitals throughout the state as part of California’s first comprehensive public system of collecting cord blood for lifesaving transplantations and medical research. [en español]
March 14, 2014
Several chemotherapy patients at the UC Davis Comprehensive Cancer Center will be invited to use tablets with a unique social networking tool as part of their treatment plan.
March 14, 2014
UC Davis researchers have found that routine information — blood pressure, respiratory rate, temperature and white blood cell count — from the electronic health records (EHRs) of hospitalized patients can be used to predict the early stages of sepsis, a leading cause of death and hospitalization in the U.S. They also determined that just three measures — lactate level, blood pressure and respiratory rate — can pinpoint the likelihood that a patient will die from the disease.
March 12, 2014
Microbes collected from Northern California and throughout the nation will soon blast into orbit for research and a microgravity growth competition on the International Space Station (ISS). This citizen science project, known as Project MERCCURI, is led in part by UC Davis microbiologists, who are investigating how microbes from different places on Earth compare to each other and to those found on the International Space Station.
March 11, 2014
The UC Davis MIND Institute has been named an Intellectual and Developmental Disabilities Research Center (IDDRC), through a prestigious grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health — a distinction held by only a handful of neurodevelopmental centers nationwide committed to the diagnosis, prevention, treatment and amelioration of developmental disorders such as autism, fragile X syndrome and Down syndrome.
March 10, 2014
The hunt is on to find biomarkers that detect cancer, but it’s a challenging process. Early successes often are followed by heartbreaking failures.
March 7, 2014
Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found.
March 5, 2014
Atypical development can be detected as early as 12 months of age among the siblings of children with autism spectrum disorder, a study published by researchers with the UC Davis MIND Institute and UCLA has found.
February 28, 2014
Sacramento-area youth in the early stages of serious mental illness can receive a new smartphone app that helps them detect early warning signs of psychosis, through a one-year, $588,000 grant to the UC Davis Early Diagnosis and Preventive Treatment (EDAPT) Clinic from the Robert Wood Johnson Foundation, to study whether harnessing mobile technology improves patient care.
February 18, 2014
Justin Siegel, a biochemist at the University of California, Davis, who uses computers to develop new "designer enzymes" with properties not found in nature, has been awarded a prestigious Sloan Research Fellowship to support his work.
February 14, 2014
When mothers feed their newborns formula in the hospital, they are less likely to fully breastfeed their babies in the second month of life and more likely to quit breastfeeding early, even if they had hoped to breastfeed longer, UC Davis researchers have found. [en español or 中文 Chinese]
February 6, 2014
Helen Wu, a research and policy scientist in the UC Davis Institute for Population Health Improvement (IPHI), has been selected to receive a Robert Wood Johnson Foundation Mentored Research Scientist Development Award under its Public Health Services and Systems Research Program.
February 2, 2014
Governments could slow — and even reverse — the growing epidemic of obesity by taking measures to counter fast food consumption, according to a study published today in the Bulletin of the World Health Organization.
January 23, 2014
Bruce D. Hammock, UC Davis Distinguished Professor of Entomology, has received the 2014 Bernard B. Brodie Award from The American Society for Pharmacology and Experimental Therapeutics (ASPET).
January 15, 2014
UC Davis placed among the nation’s leading institutions of higher education that conduct research funded by the National Institutes of Health (NIH) in 2013, according to data collected and tabulated by the Blue Ridge Institute for Medical Research, a North Carolina nonprofit organization that uses the NIH’s Research Portfolio Online Reporting Tools for its annual rankings.
January 11, 2014
In a study of the range of treatments being employed for young children with autism and other developmental delays, UC Davis MIND Institute researchers have found that families often use complementary and alternative medicine (CAM) treatments and that the most frequent users of both conventional and complementary approaches are those with higher levels of parental education and income. [en español]
January 10, 2014
Katherine A. Rauen, professor in the Department of Pediatrics and a physician-scientist affiliated with the UC Davis MIND Institute and UC Davis Children’s Hospital, has received a 2013 Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their research careers.
January 6, 2014
Even though obesity affects women and men equally, a UC Davis study shows that obese women are four times more likely than obese men to seek weight-loss surgery. When they do see a bariatric surgeon, male patients tend to be older, more obese and sicker than women.
December 31, 2013
UC Davis radiologists, medical physicists and orthopaedic surgeons have found a way to create "movies" of the wrist in motion using a series of brief magnetic resonance imaging scans. Called "Active MRI," the technique could be useful in diagnosing subtle changes in physiology that indicate the onset of conditions such as wrist instability.
December 30, 2013
High levels of “good” cholesterol and low levels of “bad” cholesterol are correlated with lower levels of the amyloid plaque deposition in the brain that is a hallmark of Alzheimer’s disease, in a pattern that mirrors the relationship between good and bad cholesterol in cardiovascular disease, UC Davis researchers have found. [en español]
December 20, 2013
Gastric cancer kills more than 700,000 people each year, mostly in Latin America, Asia and Eastern Europe. Though the disease is quite treatable when caught early, symptoms are indistinct and late detection leads to high mortality. The five-year survival rate in the United States is 26.9 percent.
December 18, 2013
Since the prostate specific antigen (PSA) test was introduced in the late 1980s, prostate cancer mortality has dropped by more than 40 percent. However, there has been tremendous controversy over whether the PSA test has caused that decline. In a newly published study, UC Davis researchers suggest that PSA screening likely plays an important role. [en español]
December 18, 2013
A study by UC Davis MIND Institute researchers has been named one of the Top 10 Scientific Advances of 2013 by Autism Speaks, the international science and advocacy organization.
December 17, 2013
Removal of the thyroid gland is considered by most surgeons to be safe, which is why patients are often discharged from the hospital on the same day as the procedure. A new international, multicenter study published in the current issue of Surgery has found that some of these patients should be monitored in the hospital overnight for potentially deadly bleeding known as a post-surgical hematoma.
December 13, 2013
More intensive screening to identify firearm owners among individuals who are subject to domestic violence restraining orders, and streamlining processes to recover guns at the time those restraining orders are served could help enforce existing laws that prohibit these offenders from having firearms and using them to harm others, a pilot study conducted by violence prevention experts at the University of Californa, Davis, and the Johns Hopkins Bloomberg School of Public Health has found. [en español]
December 12, 2013
Led by a renowned throat surgeon and a highly regarded stem cell researcher, a UC Davis team has received a $4.4 million grant from the California Institute for Regenerative Medicine (CIRM) to develop a stem cell-derived airway transplant to cure a difficult, life-threatening problem known as severe airway stenosis.
December 12, 2013
A Phase III clinical trial led by UC Davis researchers has confirmed that a new coagulation factor (rFIXFc) dramatically reduces the number of injections needed to maintain effective clotting for hemophilia B patients.
December 9, 2013
With a deluge of promising new drug treatments for advanced prostate cancer on the market, a new model of care is needed that emphasizes collaboration between urologists and medical oncologists, according to UC Davis prostate cancer experts. [en español]
December 6, 2013
Paul Knoepfler, associate professor of cell biology and human anatomy at UC Davis School of Medicine, was honored this week at the World Stem Cell Summit in San Diego for his stem cell advocacy and awareness efforts.
November 26, 2013
Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, and corneas from donors over 71 perform slightly less well but still remain healthy for most transplant recipients, according to a study funded by the National Eye Institute (NEI) and led by the UC Davis Health System Eye Center and the University of Cincinnati Eye Institute. [en español]
November 25, 2013
A new study from researchers at UC Davis has shown that telemedicine consultations from pediatric specialists reduced the number of drug errors in eight rural emergency departments. Published today in the journal Pediatrics, the study is the latest in research from UC Davis which demonstrates that telemedicine consultations can improve quality of care in rural settings. [中文 Chinese] or [en español]
November 22, 2013
People with health insurance are more likely to use preventive services such as flu shots and health screenings to reduce their risk of serious illness, but they are no more likely than people without health insurance to engage in risky health behaviors such as smoking or gaining weight, researchers at UC Davis and University of Rochester have found. [en español]
UC Davis Children's Hospital offers access to pediatric subspecialty care for rural newborns with PEANUT Program
November 13, 2013
UC Davis Children’s Hospital has been awarded a three-year, approximately $750,000 grant from the U.S. Department of Health and Human Services Office for the Advancement of Telehealth - Health Resources and Services Administration (OAT-HRSA) to expand its services for infants through the new Pediatric Emergency Assistance to Newborns Using Telehealth (PEANUT) Program.
November 6, 2013
Children with autism experience gastrointestinal (GI) upsets such as constipation, diarrhea and sensitivity to foods six-to-eight times more often than do children who are developing typically, and those symptoms are related to behavioral problems, including social withdrawal, irritability and repetitive behaviors, a new study by researchers at the UC Davis MIND Institute has found. [en español] [中文 Chinese]
November 5, 2013
Patients who used an interactive computer program about depression while waiting to see their primary-care doctor were nearly twice as likely to ask about the condition and significantly more likely to receive a recommendation for antidepressant drugs or a mental-health referral from their physician, according to a new study by researchers at UC Davis.
November 4, 2013
Using telemedicine to unite clinicians and provide health education for them — and by extension, their patients — is an effective way to manage childhood obesity in remote areas. For these communities, which often have limited access to pediatric subspecialists, having a HEALTH-COP can make all the difference. [中文 Chinese] or [en español]
November 4, 2013
As part of a national effort to broaden scientific training opportunities for young scientists and engineers and better prepare them for a wide variety of careers, the National Institutes of Health has awarded UC Davis a five-year, $1.7 million grant to support the Frontiers of University Training to Unlock the Research Enterprise (FUTURE) program ̶ a campuswide effort that will expand academic offerings, internships and other experiential learning in the biomedical sciences for graduate students and postdoctoral scholars.